IDEXX Laboratories, Inc. (0J8P.L)
USD 419.98
(-2.66%)
USD 419.98
(-2.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 906.51 Million | 542.98 Million | 755.54 Million | 648.06 Million | 459.15 Million | 400.08 Million |
| Net Income | 845.04 Million | 679.08 Million | 744.84 Million | 582.13 Million | 427.79 Million | 377.04 Million |
| Depreciation & Amortization | 114.9 Million | 111.9 Million | 104.59 Million | 95.99 Million | 88.01 Million | 83.17 Million |
| Deferred income taxes | -48.3 Million | -35.06 Million | -3.37 Million | -38.08 Million | 6.16 Million | 1.2 Million |
| Stock-based compensation | 59.73 Million | 49.77 Million | 37.75 Million | 30.95 Million | 39.27 Million | 25.15 Million |
| Change in working capital | -72.42 Million | -273.53 Million | -137.52 Million | -31.76 Million | -104.96 Million | -91.64 Million |
| Other non-cash items | 7.55 Million | 10.82 Million | 9.25 Million | 8.82 Million | 2.88 Million | 5.13 Million |
| Investing Cash Flow | -125.25 Million | -195.35 Million | -292.96 Million | -109.37 Million | -205.52 Million | 138.6 Million |
| Investments in PPE | -133.63 Million | -148.83 Million | -119.54 Million | -107.62 Million | -155.22 Million | -122.93 Million |
| Acquisitions | - | -46.51 Million | -173.41 Million | -1.75 Million | -50.3 Million | -22.5 Million |
| Investment purchases | - | -25 Million | - | - | - | -87 Thousand |
| Sales/Maturities of investments | 8.37 Million | 71.51 Million | - | - | - | 284.12 Million |
| Other Investing Activities | 8.37 Million | -46.51 Million | - | -918 Thousand | -255 Thousand | 276.85 Million |
| Financing Cash Flow | -441.99 Million | -370.93 Million | -697.41 Million | -248.41 Million | -286.4 Million | -597.79 Million |
| Debt repayment | -404 Million | -75 Million | -50 Million | -289.62 Million | -110.27 Million | -256.04 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -71.92 Million | -830.31 Million | -762.33 Million | -203.41 Million | -309.71 Million | -378.69 Million |
| Common Stock Issuance | 47.03 Million | 35.74 Million | 46.56 Million | 51.32 Million | 36.1 Million | 38.2 Million |
| Other Financing Activities | -13.11 Million | 498.63 Million | 114.92 Million | 244.62 Million | 133.57 Million | 36.93 Million |
| Accounts receivables | -53.87 Million | -41.39 Million | -33.14 Million | -60.72 Million | -22.47 Million | -18.4 Million |
| Accounts payables | -557 Thousand | 3.46 Million | 11.23 Million | 981 Thousand | 1.95 Million | -166 Thousand |
| Inventory | -28.65 Million | -121.73 Million | -52.91 Million | -18.88 Million | -37.3 Million | -25.62 Million |
| Other working capital | 10.65 Million | -113.86 Million | -62.69 Million | 46.86 Million | -47.14 Million | -47.45 Million |
| Cash at beginning of period | 112.54 Million | 144.45 Million | 383.92 Million | 90.32 Million | 123.79 Million | 187.67 Million |
| Cash at end of period | 453.93 Million | 112.54 Million | 144.45 Million | 383.92 Million | 90.32 Million | 123.79 Million |
| Capital Expenditure | -133.63 Million | -148.83 Million | -119.54 Million | -107.62 Million | -155.22 Million | -122.93 Million |
| Effect of forex changes on cash | 2.12 Million | -8.6 Million | -4.63 Million | 3.33 Million | -689 Thousand | -4.76 Million |
| Net cash flow / Change in cash | 341.38 Million | -31.9 Million | -239.47 Million | 293.6 Million | -33.46 Million | -63.88 Million |
| Free Cash Flow | 772.87 Million | 394.14 Million | 635.99 Million | 540.43 Million | 303.93 Million | 277.14 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 232.84 Million | 203.29 Million | 235.57 Million | 845.04 Million | 194.52 Million | 212.23 Million |
| Depreciation & Amortization | -62.09 Million | 32.19 Million | 29.9 Million | 114.9 Million | 29.73 Million | 28.98 Million |
| Deferred income taxes | 22.02 Million | -19.45 Million | -2.57 Million | -48.3 Million | -33.55 Million | -1.81 Million |
| Stock-based compensation | -30.1 Million | 15.7 Million | 14.4 Million | 59.73 Million | 15.22 Million | 15.22 Million |
| Change in working capital | 67.13 Million | 14.28 Million | -81.41 Million | -72.42 Million | 41.82 Million | 16.05 Million |
| Other non-cash items | -9.72 Million | 107.06 Million | 909 Thousand | 7.55 Million | 2.1 Million | 1.75 Million |
| Investing Cash Flow | -27.36 Million | -32.9 Million | -106.94 Million | -125.25 Million | -30.43 Million | -27.83 Million |
| Investments in PPE | -28.08 Million | -33.3 Million | -30.27 Million | -133.63 Million | -32.55 Million | -34.09 Million |
| Acquisitions | 306 Thousand | - | -77 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | -727 Thousand | 398 Thousand | 329 Thousand | 8.37 Million | 2.12 Million | 6.25 Million |
| Other Investing Activities | 1.14 Million | 398 Thousand | 329 Thousand | 8.37 Million | -1.00 | 6.25 Million |
| Financing Cash Flow | -290.97 Million | -210.23 Million | -144.07 Million | -441.99 Million | -101.84 Million | -43.03 Million |
| Debt repayment | -75 Million | - | - | -404 Million | -75 Million | -14 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -220.75 Million | -215.52 Million | -154.76 Million | -71.92 Million | -36.85 Million | -35.3 Million |
| Common Stock Issuance | -26.24 Million | 5.36 Million | 20.87 Million | 47.03 Million | 11.33 Million | 12.61 Million |
| Other Financing Activities | -43.98 Million | -79 Thousand | -10.18 Million | -13.11 Million | -1.32 Million | -4.97 Million |
| Accounts receivables | 82.98 Million | -29.14 Million | -53.84 Million | -53.87 Million | 686 Thousand | 6.6 Million |
| Accounts payables | -3.8 Million | 8.25 Million | -4.45 Million | -557 Thousand | 6.24 Million | -2.64 Million |
| Inventory | 6.21 Million | -3.8 Million | -2.41 Million | -28.65 Million | 2.99 Million | 7.25 Million |
| Other working capital | -18.25 Million | 38.97 Million | -20.71 Million | 10.65 Million | 31.89 Million | 4.84 Million |
| Cash at beginning of period | 401.59 Million | 397.43 Million | 453.93 Million | 112.54 Million | 331.69 Million | 132.83 Million |
| Cash at end of period | 308.63 Million | 401.59 Million | 397.43 Million | 453.93 Million | 453.93 Million | 331.69 Million |
| Capital Expenditure | -28.08 Million | -33.3 Million | -30.27 Million | -133.63 Million | -32.55 Million | -34.09 Million |
| Effect of forex changes on cash | 5.31 Million | -1.01 Million | -4.06 Million | 2.12 Million | 4.66 Million | -2.69 Million |
| Net cash flow / Change in cash | -92.95 Million | 4.15 Million | -56.49 Million | 341.38 Million | 122.23 Million | 198.85 Million |
| Free Cash Flow | 191.99 Million | 215 Million | 168.31 Million | 772.87 Million | 217.29 Million | 238.33 Million |
0JZ2
DGR
300252
2980
WCN
0K9W